Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:HIMSNYSE:SMR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHIMSHims & Hers Health$27.99-10.4%$39.97$11.20▼$72.98$6.22B1.3714.58 million shs19.63 million shsSMRNuScale Power$14.11-6.6%$19.79$4.61▼$32.30$3.99B1.588.11 million shs6.26 million shsElon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHIMSHims & Hers Health+0.40%-6.69%-23.35%+23.65%+107.87%SMRNuScale Power+2.96%-11.66%-2.52%-14.85%+163.18%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHIMSHims & Hers Health3.8348 of 5 stars4.12.00.00.02.73.31.9SMRNuScale Power1.8413 of 5 stars2.43.00.00.02.52.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHIMSHims & Hers Health 2.27Hold$37.3133.31% UpsideSMRNuScale Power 2.75Moderate Buy$15.7511.62% UpsideCurrent Analyst Ratings BreakdownLatest SMR and HIMS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/18/2025HIMSHims & Hers HealthBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderperform ➝ Underperform$21.00 ➝ $22.003/7/2025SMRNuScale PowerUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$25.00 ➝ $17.003/6/2025HIMSHims & Hers HealthBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingUnderperform ➝ Underperform$21.00 ➝ $21.003/6/2025HIMSHims & Hers HealthCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell ➝ Sell$27.00 ➝ $27.002/26/2025HIMSHims & Hers HealthTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$24.00 ➝ $39.002/25/2025HIMSHims & Hers HealthLeerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetMarket Perform ➝ Market Perform$24.00 ➝ $40.002/25/2025HIMSHims & Hers HealthPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$24.00 ➝ $35.002/25/2025HIMSHims & Hers HealthCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSell ➝ Sell$25.00 ➝ $27.002/25/2025HIMSHims & Hers HealthNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$31.00 ➝ $61.002/20/2025HIMSHims & Hers HealthBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderperform ➝ Underperform$18.00 ➝ $21.002/19/2025HIMSHims & Hers HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$38.00 ➝ $68.00(Data available from 4/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHIMSHims & Hers Health$1.48B4.21N/AN/A$1.61 per share17.38SMRNuScale Power$37.05M107.57N/AN/A$0.56 per share25.20Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHIMSHims & Hers Health-$23.55M$0.5463.6053.82N/A8.19%10.97%8.29%5/5/2025 (Estimated)SMRNuScale Power-$58.36M-$1.47N/AN/AN/A-1,089.32%-72.85%-34.32%5/8/2025 (Estimated)Latest SMR and HIMS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/24/2025Q4 2024HIMSHims & Hers Health$0.09$0.11+$0.02$0.11$494.56 million$481.14 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHIMSHims & Hers HealthN/AN/AN/AN/AN/ASMRNuScale PowerN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHIMSHims & Hers HealthN/A2.141.82SMRNuScale Power0.262.242.24Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHIMSHims & Hers Health63.52%SMRNuScale Power78.37%Insider OwnershipCompanyInsider OwnershipHIMSHims & Hers Health17.71%SMRNuScale Power1.96%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHIMSHims & Hers Health650222.17 million179.79 millionOptionableSMRNuScale Power440282.43 million250.36 millionOptionableSMR and HIMS HeadlinesRecent News About These CompaniesNuScale Power Unusual Options ActivityApril 3 at 5:46 AM | nasdaq.comUniversity of Nevada, Las Vegas Opens NuScale Power Energy Exploration (E2) Center™April 2 at 4:30 PM | businesswire.comNuscale Power Becomes Oversold (SMR)April 2 at 2:44 PM | nasdaq.comNuScale Power (NYSE:SMR) Stock Price Up 2.5% - Here's What HappenedApril 2 at 1:40 PM | marketbeat.comRPI and NuScale launch hands-on nuclear training labApril 2 at 9:43 AM | neimagazine.comNuScale Power (NYSE:SMR) Trading 3.8% Higher - Time to Buy?April 1 at 2:43 PM | marketbeat.comNuScale Power (NYSE:SMR) Shares Gap Up - Here's WhyApril 1 at 10:56 AM | marketbeat.com167,309 Shares in NuScale Power Co. (NYSE:SMR) Acquired by Headlands Technologies LLCApril 1 at 6:36 AM | marketbeat.comIs NuScale Power Stock a Millionaire Maker?April 1 at 4:33 AM | fool.comMini nuclear reactor rush has a short half-lifeMarch 31 at 7:24 PM | reuters.comNuScale Power Corporation: Warrant Redemption Bought Time, But Significant Risks RemainMarch 31 at 7:24 PM | seekingalpha.comNuScale Power (NYSE:SMR) Stock Price Down 5.6% - What's Next?March 31 at 2:45 PM | marketbeat.com37,602 Shares in NuScale Power Co. (NYSE:SMR) Purchased by Teacher Retirement System of TexasMarch 31 at 3:20 AM | marketbeat.comWhere Will NuScale Power Be in 5 Years?March 30, 2025 | fool.com153,639 Shares in NuScale Power Co. (NYSE:SMR) Acquired by Raymond James Financial Inc.March 29, 2025 | marketbeat.comNuScale Power: The Bottom Isn't In Yet (Technical Analysis)March 29, 2025 | seekingalpha.comNuScale Power (NYSE:SMR) Shares Down 5% - What's Next?March 28, 2025 | marketbeat.comNew nuclear energy technology exploration bill passes Delaware houseMarch 27, 2025 | wdel.comNuScale Power (NYSE:SMR) Stock Price Down 1.5% - Here's What HappenedMarch 27, 2025 | marketbeat.comSwiss National Bank Purchases 29,300 Shares of NuScale Power Co. (NYSE:SMR)March 27, 2025 | marketbeat.comEighth NuScale SMR simulator openedMarch 26, 2025 | world-nuclear-news.orgNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWarren Buffett Swaps VOO for This Reliable Dividend StockBy Sarah Horvath | March 7, 2025View Warren Buffett Swaps VOO for This Reliable Dividend StockNVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a BuyBy Thomas Hughes | March 12, 2025View NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a BuyBYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?By Jeffrey Neal Johnson | March 21, 2025View BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?3 Defense Stocks Set to Benefit From Increased Military SpendingBy Chris Markoch | March 20, 2025View 3 Defense Stocks Set to Benefit From Increased Military SpendingMissed the Hims & Hers Rally? Clover Health Could Be NextBy Gabriel Osorio-Mazilli | March 5, 2025View Missed the Hims & Hers Rally? Clover Health Could Be NextSMR and HIMS Company DescriptionsHims & Hers Health NYSE:HIMS$27.98 -3.24 (-10.36%) Closing price 03:58 PM EasternExtended Trading$28.05 +0.07 (+0.23%) As of 06:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.NuScale Power NYSE:SMR$14.11 -1.00 (-6.62%) Closing price 03:58 PM EasternExtended Trading$14.16 +0.05 (+0.39%) As of 06:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NuScale Power Corporation engages in the development and sale of modular light water reactor nuclear power plants to supply energy for electrical generation, district heating, desalination, hydrogen production, and other process heat applications. It offers NuScale Power Module (NPM), a water reactor that can generate 77 megawatts of electricity (MWe); and VOYGR power plant designs for three facility sizes that are capable of housing from one to four and six or twelve NPMs. The company was founded in 2007 and is headquartered in Portland, Oregon. NuScale Power Corporation operates as a subsidiary of Fluor Enterprises, Inc. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Broadcom’s VMware Strategy Could Fuel the Next AVGO Rally Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy? Celsius Heats Up: Acquisition, Analyst Upgrade Fuel Momentum 5 Reasons Why Halliburton Is a Good Buy in 2025 First Watch Restaurant Group: A First-Rate Small-Cap Growth Stock Tesla Stock: What To Expect With Their Delivery Numbers Report Rocket Lab: $5.6 Billion Defense Contract Fuels RKLB’s Future Equinix: A Smart Bet on Data Centers, Dividends, and AI Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
